FIG. 4.
Anti-SARS-CoV-specific neutralization antibody response in Indian rhesus macaques after ADS-MVA vaccinations. Four animals (I624, N462, V876, and P283) were immunized i.m. twice, 4 weeks apart, with 1 × 108 and 3 × 108 TCID50 of ADS-MVA per animal, respectively. Another four macaques (AG11, AT14, I826, and V873) were treated the same but with ADC-MVA. (A) Neutralizing antibody responses after the first immunization. (B) Boosted neutralizing antibody responses after the second immunization.
